Company logo

AMN - AMN Healthcare Services, Inc.

NYSE -> Healthcare -> Medical Care Facilities
Dallas, United States
Type: Equity

AMN price evolution
AMN
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Current assets
Cash $101.78 $99.37 $78.58 $96.11
Short term investments
Net receivables $741.19 $741.7 $748.16 $964.3
Inventory
Total current assets $841.68 $831.12 $807.24 $1071.06
Long term investments
Property, plant & equipment $191.38 $187.56 $177.42 $155.28
Goodwill & intangible assets $1585.68 $1345.58 $1368.14 $1389.8
Total noncurrent assets $2082.71 $1823.65 $1836.91 $1810
Total investments
Total assets $2924.39 $2654.77 $2644.14 $2881.06
Current liabilities
Accounts payable $343.85 $362.91 $327.54 $473.76
Deferred revenue
Short long term debt
Total current liabilities $656.12 $707.13 $673.72 $803.6
Long term debt $1304.69 $939.39 $1034.1 $983.8
Total noncurrent liabilities $1437.02 $1130.47 $1204.13 $1121.69
Total debt $1304.69 $939.39 $1034.1 $983.8
Total liabilities $2093.14 $1837.6 $1877.85 $1925.29
Shareholders' equity
Retained earnings $1451.67 $1439.19 $1386.01 $1325.11
Other shareholder equity -$0.42 -$0.61 -$0.74 -$0.79
Total shareholder equity $831.26 $817.17 $766.3 $955.77
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $101.78 $125.74 $245.41 $90.56
Short term investments
Net receivables $741.19 $953.25 $1028.85 $450.08
Inventory
Total current assets $841.68 $1093.64 $1349.07 $533.74
Long term investments
Property, plant & equipment $191.38 $165.54 $154.88 $193.91
Goodwill & intangible assets $1585.68 $1412.2 $1406.8 $1429.4
Total noncurrent assets $2082.71 $1794.71 $1782.84 $1819.77
Total investments
Total assets $2924.39 $2888.35 $3131.91 $2353.51
Current liabilities
Accounts payable $343.85 $78.06 $425.26 $167.88
Deferred revenue $11.82 $15.95 $11
Short long term debt $8.09 $11.38 $19.72
Total current liabilities $656.12 $857.93 $969.39 $422.96
Long term debt $1304.69 $843.5 $855.69 $935.76
Total noncurrent liabilities $1437.02 $986.78 $1000.49 $1110.87
Total debt $1304.69 $860.96 $867.07 $955.48
Total liabilities $2093.14 $1844.72 $1969.88 $1533.83
Shareholders' equity
Retained earnings $1451.67 $1241 $796.95 $469.56
Other shareholder equity -$0.42 -$0.94 -$0.29 $0.04
Total shareholder equity $831.26 $1043.63 $1162.03 $819.68
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Revenue
Total revenue $818.27 $853.46 $991.3 $1126.22
Cost of revenue $557.32 $563.96 $661.02 $757.38
Gross Profit $260.95 $289.51 $330.28 $368.85
Operating activities
Research & development
Selling, general & administrative $185.46 $163.41 $201.77 $205.6
Total operating expenses $226.78 $202.58 $238.62 $243.18
Operating income $34.17 $86.93 $91.66 $125.67
Income from continuing operations
EBIT $34.17 $86.93 $91.66 $125.67
Income tax expense $1.52 $22.21 $18.58 $31.3
Interest expense $20.16 $11.54 $12.18 $10.26
Net income
Net income $12.49 $53.17 $60.91 $84.11
Income (for common shares) $12.49 $53.17 $60.91 $84.11
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $3789.25 $5243.24 $3984.24 $2393.71
Cost of revenue $2539.67 $3526.56 $2674.63 $1601.94
Gross Profit $1249.58 $1716.68 $1309.6 $791.78
Operating activities
Research & development
Selling, general & administrative $756.24 $936.58 $730.45 $549.75
Total operating expenses $911.15 $1069.58 $831.6 $642.51
Operating income $338.43 $647.1 $478 $149.26
Income from continuing operations
EBIT $338.43 $647.1 $478 $149.26
Income tax expense $73.61 $162.65 $116.53 $20.86
Interest expense $54.14 $40.4 $34.08 $57.74
Net income
Net income $210.68 $444.05 $327.39 $70.67
Income (for common shares) $210.68 $444.05 $327.39 $70.67
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income $12.49 $53.17 $60.91 $84.11
Operating activities
Depreciation $43.6 $42.11 $38.22 $38.61
Business acquisitions & disposals -$292.18
Stock-based compensation $2.58 $0.31 $4.82 $10.32
Total cash flows from operations -$41.13 $172.19 $197.67 $43.43
Investing activities
Capital expenditures -$29.86 -$29.89 -$26.45 -$17.49
Investments $2.98 $4.98 $2.01
Total cash flows from investing -$323.73 -$33.9 -$22.43 -$32.43
Financing activities
Dividends paid
Sale and purchase of stock -$250 -$174.74
Net borrowings $364.7 -$95 $50 $136.42
Total cash flows from financing $363.5 -$105.02 -$203.29 -$44.46
Effect of exchange rate
Change in cash and equivalents -$1.37 $33.27 -$28.05 -$33.45
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income $210.68 $444.05 $327.39 $70.67
Operating activities
Depreciation $162.55 $142.61 $107.5 $93.6
Business acquisitions & disposals -$292.18 -$69.57 -$42.69 -$476.43
Stock-based compensation $18.02 $30.07 $25.22 $20.46
Total cash flows from operations $372.17 $653.73 $305.36 $256.83
Investing activities
Capital expenditures -$103.69 -$75.83 -$53.57 -$37.7
Investments $9.97 $1.3 -$3.48 -$15.47
Total cash flows from investing -$412.49 -$170.71 -$107.4 -$538.17
Financing activities
Dividends paid
Sale and purchase of stock -$424.74 -$576.77 -$2.69
Net borrowings $456.12 -$21.88 $229.04
Total cash flows from financing $10.73 -$591.87 -$34.9 $211.49
Effect of exchange rate -$0.34 -$0.11
Change in cash and equivalents -$29.6 -$108.84 $162.72 -$69.97
Fundamentals
Market cap $2.32B
Enterprise value $3.53B
Shares outstanding 37.79M
Revenue $3.79B
EBITDA $500.98M
EBIT $338.43M
Net Income $210.68M
Revenue Q/Q -27.30%
Revenue Y/Y N/A
P/E ratio 11.03
EV/Sales 0.93
EV/EBITDA 7.04
EV/EBIT 10.42
P/S ratio 0.61
P/B ratio 2.79
Book/Share 22.01
Cash/Share 2.69
EPS $5.58
ROA 7.59%
ROE 25.00%
Debt/Equity 2.52
Net debt/EBITDA 3.97
Current ratio 1.28
Quick ratio 1.28